0001209191-19-021277.txt : 20190325 0001209191-19-021277.hdr.sgml : 20190325 20190325214655 ACCESSION NUMBER: 0001209191-19-021277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190321 FILED AS OF DATE: 20190325 DATE AS OF CHANGE: 20190325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patton Stephana Eilene CENTRAL INDEX KEY: 0001698237 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 19703973 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-21 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001698237 Patton Stephana Eilene C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 0 1 0 0 See Remarks Stock Option ( Right to Buy) 14.31 2019-03-21 4 A 0 90000 0.00 A 2029-03-20 Common Shares 90000 90000 D The option will vest as to 25% of the option shares on March 18, 2020 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date. General Counsel, Corporate Secretary, and Chief Compliance Officer /s/ Stephana Patton 2019-03-25